DXCM vs GNTX · P/E 63, rev $2.50B vs P/E 14, rev $2.53B
DexCom Inc (DXCM) versus Gentex Corporation (GNTX) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Gentex Corporation (GNTX) is a auto parts company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported GNTX revenue for 2025-12-31 was $2.53B. Net income was $384.8M. GNTX currently screens at market cap $5.33B and trailing P/E 14.1.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. GNTX currently screens at market cap $5.33B and trailing P/E 14.1.
Not investment advice. Open the DXCM and GNTX stock pages for the full models.
Not investment advice.